---
document_datetime: 2023-09-21 19:24:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kigabeq-epar-all-authorised-presentations_en.pdf
document_name: kigabeq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6923303
conversion_datetime: 2025-12-26 09:08:27.427168
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                    | (Invented) name   | Strength      | Pharmaceutical Form           | Route of Administration                     | Immediate Packaging         | Pack size              |
|-----------------------------------|-------------------|---------------|-------------------------------|---------------------------------------------|-----------------------------|------------------------|
| EU/1/18/1302/001 EU/1/18/1302/002 | KIGABEQ KIGABEQ   | 100 mg 500 mg | Soluble tablet Soluble tablet | Gastric use, Oral use Gastric use, Oral use | bottle (HDPE) bottle (HDPE) | 100 tablets 50 tablets |